Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slim Fourati

Showing results (31-40 of 185) with videos related to

Pageof 19
Sort By:
Intensive Care Medicine|July 24, 2019
Paracetamol absorption test to detect poor enteric absorption of oseltamivir in intensive care unit patients with severe influenza: a pilot studyFaten May, Gilles Peytavin, Slim Fourati, et al.
Hepatology (Baltimore, Md.)|March 31, 2023
Virological characterization of treatment failures and retreatment outcomes in patients infected with "unusual" HCV genotype 1 subtypesErwan Vo-Quang, Alexandre Soulier, Mélissa Ndebi, et al.
Emerging Infectious Diseases|May 6, 2022
Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022Slim Fourati, Guillaume Gautier, Myriam Chovelon, et al.
JAMA Oncology|January 7, 2022
SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer AgentsCharlotte Fenioux, Luis Teixeira, Slim Fourati, et al.
Antiviral Therapy|May 22, 2019
Performance assessment of a fully automated deep sequencing platform for HCV resistance testingChristophe Rodriguez, Mélanie Mercier-Darty, Alexandre Soulier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2021
BNT162b2 Messenger RNA Vaccination Did Not Prevent an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 Variant 501Y.V2 in an Elderly Nursing Home but Reduced Transmission and Disease SeverityBenoit Bailly, Luc Guilpain, Kevin Bouiller, et al.
Pathogens (Basel, Switzerland)|January 21, 2023
Impact of a Dedicated Pretransplant Infectious Disease Consultation on Respiratory Tract Infections in Kidney Allograft Recipients: A Retrospective Study of 516 RecipientsElsa Feredj, Etienne Audureau, Anna Boueilh, et al.
Infectious Diseases and Therapy|March 18, 2025
Risk of Severe COVID-19 in Four Immunocompromised Populations: A French Expert PerspectivePaul Loubet, Ilies Benotmane, Slim Fourati, et al.
BMC Infectious Diseases|March 5, 2014
Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational studySuhaib Hattab, Amelie Guihot, Marguerite Guiguet, et al.
The Journal of Infectious Diseases|February 3, 2025
Molecular characterization of RSV infections in elderly patients during the 2023/2024 season in the era of nirsevimab introductionAmandine Caillault, Laurent Softic, Pierre Bay, et al.
Pageof 19

Showing results (31-40 of 185) with videos related to

Sort By:
Pageof 19
Intensive Care Medicine|July 24, 2019
Paracetamol absorption test to detect poor enteric absorption of oseltamivir in intensive care unit patients with severe influenza: a pilot studyFaten May, Gilles Peytavin, Slim Fourati, et al.
Hepatology (Baltimore, Md.)|March 31, 2023
Virological characterization of treatment failures and retreatment outcomes in patients infected with "unusual" HCV genotype 1 subtypesErwan Vo-Quang, Alexandre Soulier, Mélissa Ndebi, et al.
Emerging Infectious Diseases|May 6, 2022
Persistent SARS-CoV-2 Alpha Variant Infection in Immunosuppressed Patient, France, February 2022Slim Fourati, Guillaume Gautier, Myriam Chovelon, et al.
JAMA Oncology|January 7, 2022
SARS-CoV-2 Antibody Response to 2 or 3 Doses of the BNT162b2 Vaccine in Patients Treated With Anticancer AgentsCharlotte Fenioux, Luis Teixeira, Slim Fourati, et al.
Antiviral Therapy|May 22, 2019
Performance assessment of a fully automated deep sequencing platform for HCV resistance testingChristophe Rodriguez, Mélanie Mercier-Darty, Alexandre Soulier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2021
BNT162b2 Messenger RNA Vaccination Did Not Prevent an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 Variant 501Y.V2 in an Elderly Nursing Home but Reduced Transmission and Disease SeverityBenoit Bailly, Luc Guilpain, Kevin Bouiller, et al.
Pathogens (Basel, Switzerland)|January 21, 2023
Impact of a Dedicated Pretransplant Infectious Disease Consultation on Respiratory Tract Infections in Kidney Allograft Recipients: A Retrospective Study of 516 RecipientsElsa Feredj, Etienne Audureau, Anna Boueilh, et al.
Infectious Diseases and Therapy|March 18, 2025
Risk of Severe COVID-19 in Four Immunocompromised Populations: A French Expert PerspectivePaul Loubet, Ilies Benotmane, Slim Fourati, et al.
BMC Infectious Diseases|March 5, 2014
Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational studySuhaib Hattab, Amelie Guihot, Marguerite Guiguet, et al.
The Journal of Infectious Diseases|February 3, 2025
Molecular characterization of RSV infections in elderly patients during the 2023/2024 season in the era of nirsevimab introductionAmandine Caillault, Laurent Softic, Pierre Bay, et al.
Pageof 19